Chardan Capital Reiterates “Buy” Rating for Ocugen (NASDAQ:OCGN)
Ocugen (NASDAQ:OCGN – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Chardan Capital in a research note issued on Monday,Benzinga reports. They currently have a $6.00 price objective on the stock. Other research analysts also recently issued research reports about the company. Maxim Group assumed coverage on Ocugen in a […]
More Stories
Who is Tiger Woods? Age, Marriage, Children, and Recent Controversy
Tiger Woods is one of the most famous American golfers. He is known as one of the greatest golf players...
Oil Falls, Stocks Jump on Renewed Hopes of Iran War Ending
By Tom Ozimek Oil prices dropped and stocks around the world rallied on April 1 on renewed hopes of a...
US Appeals Court Blocks Judge’s Rulings Against Trump Immigration Detention Policy
By Jack Phillips A U.S. appeals court on Tuesday halted a federal judge’s nationwide rulings that blocked the Trump administration...
Trump Says He’s Strongly Considering Pulling US Out of NATO
By Guy Birchall U.S. President Donald Trump said he is strongly considering withdrawing the United States from NATO, in comments...
Iran’s Top Leader Issues Statement Saying Regime Will Keep Backing Anti-Israel Forces
By Jack Phillips Iran’s top leader released a new statement on April 1 saying the Iranian regime will continue to...
Who is Jessi Draper? Know about her kissing drama with Chase McWhorter
Who is Jessi Draper? A star member of Hulu’s popular reality series, Secret Lives of Mormon Wives, has again stepped...